Xtant Medical Holdings Company Profile (AMEX:XTNT)

About Xtant Medical Holdings (AMEX:XTNT)

Xtant Medical Holdings logoXtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: AMEX:XTNT
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: $7.8 million
  • Outstanding Shares: 17,933,000
Average Prices:
  • 50 Day Moving Avg: $0.50
  • 200 Day Moving Avg: $0.53
  • 52 Week Range: $0.29 - $2.37
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.89
  • P/E Growth: -0.020
Sales & Book Value:
  • Annual Revenue: $91.11 million
  • Price / Sales: 0.09
  • Book Value: ($0.65) per share
  • Price / Book: -0.67
Profitability:
  • EBIDTA: $1.73 million
Misc:
  • Average Volume: 869,364 shs.
  • Short Ratio: 1.69
 

Frequently Asked Questions for Xtant Medical Holdings (AMEX:XTNT)

What is Xtant Medical Holdings' stock symbol?

Xtant Medical Holdings trades on the AMEX under the ticker symbol "XTNT."

How were Xtant Medical Holdings' earnings last quarter?

Xtant Medical Holdings Inc (AMEX:XTNT) issued its earnings results on Tuesday, May, 9th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.30) by $0.01. The business had revenue of $22.08 million for the quarter. View Xtant Medical Holdings' Earnings History.

Where is Xtant Medical Holdings' stock going? Where will Xtant Medical Holdings' stock price be in 2017?

3 brokers have issued 1-year target prices for Xtant Medical Holdings' stock. Their forecasts range from $1.50 to $3.50. On average, they expect Xtant Medical Holdings' stock price to reach $2.50 in the next year. View Analyst Ratings for Xtant Medical Holdings.

Who are some of Xtant Medical Holdings' key competitors?

Who owns Xtant Medical Holdings stock?

Xtant Medical Holdings' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Perkins Capital Management Inc. (3.79%) and KCG Holdings Inc. (0.00%). Company insiders that own Xtant Medical Holdings stock include Daniel S Goldberger, David Louis Kirschman and Kent L Swanson. View Institutional Ownership Trends for Xtant Medical Holdings.

Who sold Xtant Medical Holdings stock? Who is selling Xtant Medical Holdings stock?

Xtant Medical Holdings' stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. View Insider Buying and Selling for Xtant Medical Holdings.

Who bought Xtant Medical Holdings stock? Who is buying Xtant Medical Holdings stock?

Xtant Medical Holdings' stock was bought by a variety of institutional investors in the last quarter, including KCG Holdings Inc.. Company insiders that have bought Xtant Medical Holdings stock in the last two years include Daniel S Goldberger, David Louis Kirschman and Kent L Swanson. View Insider Buying and Selling for Xtant Medical Holdings.

How do I buy Xtant Medical Holdings stock?

Shares of Xtant Medical Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Xtant Medical Holdings stock cost?

One share of Xtant Medical Holdings stock can currently be purchased for approximately $0.44.

Analyst Ratings

Consensus Ratings for Xtant Medical Holdings (AMEX:XTNT) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.50

Analysts' Ratings History for Xtant Medical Holdings (AMEX:XTNT)
Show:
DateFirmActionRatingPrice TargetDetails
5/22/2017Maxim GroupReiterated RatingBuy$1.50View Rating Details
11/30/2016AegisInitiated CoverageBuy$3.50View Rating Details
8/4/2016HC WainwrightReiterated RatingBuyView Rating Details
3/17/2016Brean CapitalReiterated RatingBuy$10.00View Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for Xtant Medical Holdings (AMEX:XTNT)
Earnings by Quarter for Xtant Medical Holdings (AMEX:XTNT)
Earnings History by Quarter for Xtant Medical Holdings (AMEX:XTNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.30)($0.29)$22.08 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.30)($0.31)$24.45 million$24.47 millionViewListenView Earnings Details
5/4/2016Q1($0.39)($0.44)$21.94 million$20.98 millionViewN/AView Earnings Details
3/15/2016Q415($0.22)$0.97$23.34 million$22.30 millionViewN/AView Earnings Details
11/11/2015Q3($0.15)($0.64)$19.64 million$17.69 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Xtant Medical Holdings (AMEX:XTNT)
Current Year EPS Consensus Estimate: $-0.890 EPS
Next Year EPS Consensus Estimate: $-0.490 EPS

Dividends

Dividend History for Xtant Medical Holdings (AMEX:XTNT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Xtant Medical Holdings (AMEX:XTNT)
Insider Trades by Quarter for Xtant Medical Holdings (AMEX:XTNT)
Institutional Ownership by Quarter for Xtant Medical Holdings (AMEX:XTNT)
Insider Trades by Quarter for Xtant Medical Holdings (AMEX:XTNT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2016Daniel S GoldbergerCEOBuy5,000$2.34$11,700.00View SEC Filing  
12/3/2015Kent L. SwansonDirectorBuy3,300$2.83$9,339.00View SEC Filing  
11/20/2015David Louis KirschmanEVPBuy2,000$2.99$5,980.00View SEC Filing  
11/20/2015Kent L. SwansonDirectorBuy5,000$3.00$15,000.00View SEC Filing  
11/19/2015David Louis KirschmanEVPBuy2,000$2.90$5,800.00View SEC Filing  
11/16/2015Daniel S GoldbergerCEOBuy3,000$2.80$8,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Xtant Medical Holdings (AMEX:XTNT)
Latest Headlines for Xtant Medical Holdings (AMEX:XTNT)
Source:
DateHeadline
globenewswire.com logoXtant Medical Announces Rescheduling of Annual Meeting - GlobeNewswire (press release)
globenewswire.com - May 27 at 6:56 AM
americanbankingnews.com logoXtant Medical Holdings Inc (XTNT) Receives "Buy" Rating from Maxim Group
www.americanbankingnews.com - May 22 at 10:54 AM
seekingalpha.com logoXtant Medical in-licenses Sites Medical's OsteoSync Ti
seekingalpha.com - May 17 at 12:15 AM
streetinsider.com logoXtant Medical Holdings (XTNT) Announces Licensing Agreement for Sites Medical's OsteoSync Ti Technology - StreetInsider.com
www.streetinsider.com - May 16 at 8:03 AM
finance.yahoo.com logoXtant Medical Enters into Licensing Agreement for Sites Medical’s OsteoSync Ti Technology
finance.yahoo.com - May 16 at 8:03 AM
seekingalpha.com logoXtant Medical Holdings' (XTNT) CEO Carl O'Connell on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 15 at 8:17 AM
seekingalpha.com logoXtant Medical Holdings, Inc. 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 14 at 12:06 PM
finance.yahoo.com logoXtant Medical Announces OrbiMed Financing and Engagement of Aurora Management Partners
finance.yahoo.com - May 12 at 3:19 PM
finance.yahoo.com logoEdited Transcript of XTNT earnings conference call or presentation 10-May-17 2:00pm GMT
finance.yahoo.com - May 12 at 3:19 PM
americanbankingnews.com logoXtant Medical Holdings Inc (XTNT) Announces Earnings Results
www.americanbankingnews.com - May 10 at 3:10 PM
finance.yahoo.com logoXtant™ Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period
finance.yahoo.com - May 9 at 8:21 PM
finance.yahoo.com logoXtant Medical Announces Release of First Quarter 2017 Results on May 9, 2017
finance.yahoo.com - May 1 at 7:50 PM
americanbankingnews.com logoXtant Medical Holdings (XTNT) Getting Favorable News Coverage, Study Finds
www.americanbankingnews.com - May 1 at 2:10 PM
americanbankingnews.com logoXtant Medical Holdings Inc (XTNT) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 30 at 7:33 AM
americanbankingnews.com logoXtant Medical Holdings (XTNT) Receiving Positive News Coverage, Report Shows
www.americanbankingnews.com - April 26 at 8:13 AM
reuters.com logoBRIEF-Xtant, units entered forbearance agreement with Silicon Valley Bank
www.reuters.com - April 25 at 8:25 AM
finance.yahoo.com logoXtant Medical Recognized as Montana Ambassador Business of the Year
finance.yahoo.com - April 25 at 8:25 AM
americanbankingnews.com logoXtant Medical Holdings (XTNT) Receives Media Impact Score of -0.35
www.americanbankingnews.com - April 21 at 7:47 AM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 8:31 AM
biz.yahoo.com logoQ4 2016 Xtant Medical Holdings Inc Earnings Release - After Market Close
biz.yahoo.com - March 10 at 6:43 AM
finance.yahoo.com logoXtant™ Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period
finance.yahoo.com - March 10 at 6:43 AM
finance.yahoo.com logoXtant Medical to announce Fourth Quarter and Full Year 2016 Results on March 9th, 2017
finance.yahoo.com - March 2 at 5:05 AM
seekingalpha.com logoXTNT @ 35c This Low Floater Could Be A Big Gainer In 2017 And Beyond. Analysts Average PT Is $3.1/Share
seekingalpha.com - February 2 at 6:56 AM
streetinsider.com logoXtant Medical Holdings (XTNT) Announces Resignation of CEO Dan Goldberger
www.streetinsider.com - January 24 at 5:26 AM
seekingalpha.com logoXtant Medical chief bids adieu
seekingalpha.com - January 24 at 5:26 AM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or P
biz.yahoo.com - January 24 at 5:26 AM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin
biz.yahoo.com - January 21 at 6:01 AM
seekingalpha.com logoXtant Medical issues new convertible debt to cover $1.6M in interest obligations
seekingalpha.com - January 19 at 4:32 PM
us.rd.yahoo.com logoCoverage initiated on Xtant Medical by Maxim Group
us.rd.yahoo.com - December 8 at 2:19 PM

Social

Social activity is not available for this stock.
This page was last updated on 5/27/2017 by MarketBeat.com Staff